Websites, domains, hosts that links to medinfo.novartispharmaceuticals.com

Our database shows, that the website medinfo.novartispharmaceuticals.com is linked by a total of 4 websites.

Number of websites/domains displayed: 4
Results found: 4

Websites discovered:

IL-17A Antagonist for PsO, PsA, & AS - COSENTYX (secukinumab)

http://pageoverview.com/website-report/cosentyxhcp.com

Learn about COSENTYX (secukinumab), the first fully human IL-17A antagonist approved for plaque psoriasis, psoriatic arthritis, andankylosing spondylitis.

Expected expiration: May 18th in 2019
Creation date: May 18th in 2015
Renew date: April 17th in 2017

Multiple Sclerosis Treatment | EXTAVIA

http://pageoverview.com/website-report/extaviahcp.com

EXTAVIA is a disease-modifying therapy (DMT) for people with relapsing forms of multiple sclerosis (MS). Learn about multiple sclerosis treatment and therapy.

Expected expiration: May 18th in 2019
Creation date: May 18th in 2015
Renew date: April 17th in 2017

Chronic Heart Failure (HFrEF) Treatment – ENTRESTO (sacubitril/valsartan) tablets

http://pageoverview.com/website-report/entrestohcp.com

Learn about ENTRESTO (sacubitril/valsartan), the HFrEF treatment for patients with chronic heart failure (NYHA Class II–IV) and reduced ejection fraction.

Expected expiration: May 7th in 2019
Creation date: May 7th in 2015
Renew date: April 6th in 2017

Relapsing-remitting MS Treatment – Gilenya (fingolimod)

http://pageoverview.com/website-report/gilenyahcp.com

Learn more about Gilenya, a sphingosine 1-phosphate receptor modulator indicated for the treatment of patients with relapsing-remitting MS. See ISI for details.

Expected expiration: May 18th in 2019
Creation date: May 18th in 2015
Renew date: April 17th in 2017